Is HFNC noninferior to NIV for Acute Respiratory Failure?

January 24, 2025 00:31:44
Is HFNC noninferior to NIV for Acute Respiratory Failure?
Critical Care Perspectives in Emergency Medicine
Is HFNC noninferior to NIV for Acute Respiratory Failure?

Jan 24 2025 | 00:31:44

/

Show Notes

Both NIV and HFNC are used to treat patients with acute respiratory failure.  Current guidelines recommend NIV for acute respiratory failure caused by COPD and acute cardiogenic pulmonary edema.  However, NIV may be hard for some patients to tolerate. When compared to low-flow oxygen therapy, HFNC has been shown to improve oxygenation, improve alveolar recruitment, and enhance clearance of secretions. HFNC may be easier to use and tolerate than NIV, but there remains uncertainty regarding the effectiveness of HFNC compared to NIV for acute hypoxemic respiratory failure. In this podcast, we discuss the RENOVATE trial that sought to compare HFNC with NIV on rates of intubation in patients with acute respiratory failure.

Other Episodes

Episode 0

November 11, 2019 00:21:11
Episode Cover

The PrePARE Trial - Do IVFs Prevent Peri-Intubation CV Collapse?

Up to 25% of critically ill patients who undergo RSI and endotracheal intubation (ETI) may suffer cardiovascular collapse.? Many clinicians administer IVFs during RSI...

Listen

Episode 0

February 21, 2022 00:24:01
Episode Cover

Ketamine or Etomidate for RSI?

Etomidate and ketamine are frequently used for RSI in critically ill patients.  Recent articles have raised concern about an increased incidence of post-intubation hypotension...

Listen

Episode 0

August 26, 2019 00:27:15
Episode Cover

Updates in Post-Arrest Care

Over 500,000 patients suffer sudden cardiac arrest each year in the United States.  Though survival rates are improving, there remains significant variation in outcomes...

Listen